Company Filing History:
1 out of 9 
1 out of 154 
1 out of 5,089 
Years Active: 2020
Title: Innovator Spotlight: Klervi Even-Desrumaux
Introduction:
Meet Klervi Even-Desrumaux, a brilliant inventor from Antony, France, who has made significant contributions to the field of biotechnology with his groundbreaking patent.
Latest Patents:
Klervi Even-Desrumaux's notable patent titled "Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule" revolutionizes the regulated expression of a chimeric antigen receptor (CAR) within a lentiviral vector. This innovation has incredible potential in inducing immune responses and treating cancers and tumors in humans.
Career Highlights:
With a total of 1 patent to his name, Klervi has established himself as a pioneer in the field of biotechnology. He has worked with esteemed companies such as Theravectys and Institut Curie, where his innovative ideas have flourished.
Collaborations:
Throughout his career, Klervi Even-Desrumaux has collaborated closely with industry experts such as Sophie Agaugue and Lorenzo Tibaldi. Together, they have pushed the boundaries of science and technology, creating impactful solutions for the betterment of society.
Conclusion:
In conclusion, Klervi Even-Desrumaux's inventive spirit and dedication to pushing the limits of innovation have positioned him as a trailblazer in the field of biotechnology. His work continues to inspire and pave the way for future advancements in medical research and treatment modalities.